Communiqués D. Western Therapeutics Institute, Inc.

Actions

Marché Fermé - Japan Exchange 08:30:00 24/09/2026			Varia. 5j.	Varia. 1 janv.
71,00 ^JPY	+2,90%		+5,97%	-26,04%

13/08	D. Western Therapeutics Institute, Inc. publie ses résultats pour le premier semestre clos le 30 juin 2026	CI
15/05	D. Western Therapeutics Institute, MEDRx et Terrain Pharmaceuticals concluent un accord de partenariat commercial aux États-Unis pour le Bondlido	CI

13/02	D Western Therapeutics Institute : Consolidated Financial Results for the Fiscal Year Ended December 31, 2025 (Based on Japanese GAAP) 221KB	PU
13/11	D Western Therapeutics Institute : Consolidated Financial Results for the Nine Months Ended September 30, 2025 (Based on Japanese GAAP)	PU
14/08/25	D Western Therapeutics Institute : Q2 FY12/25 Financial Results Briefing Materials	PU
14/02/25	D Western Therapeutics Institute : FY12/24 Financial Results Briefing Materials	PU
09/08/24	D Western Therapeutics Institute : Q2 FY12/24 Financial Results Briefing Materials	PU
10/08/23	D Western Therapeutics Institute : Summary of Consolidated Financial Results for the Six Months Ended June 30, 2023(Based on Japanese GAAP)	PU
13/02/23	D Western Therapeutics Institute : FY12/22 Financial Results Briefing Materials	PU
14/02/22	D Western Therapeutics Institute : Summary of Consolidated Financial Results for the Year Ended December 31, 2021(Based on Japanese GAAP)	PU